Align Technology (ALGN): financials, SEC filings and peers
Align Technology (ALGN) is a health care supplies company in the Health Care sector of the S&P 500, headquartered in Tempe, Arizona.
It was founded in 1997 and joined the S&P 500 on June 19, 2017.
Its fiscal year ends in December, and its shares trade on the Nasdaq.
In its SEC filings it is classified as “Orthopedic, Prosthetic & Surgical Appliances & Supplies”.
Align Technology at a glance
- Revenue (12 months)
- $4.2B
- Revenue growth
- +4.4%
- Operating margin
- 14.9%
- Net income (12 months)
- $492M
- Free cash flow (12 months)
- $603M
- Cash
- $1.1B
- Debt
- —
- Diluted EPS (12 months)
- $6.86
Twelve months to September 30, 2026, from the 10-Q filed November 4, 2026.
Latest twelve months
Over the twelve months to September 30, 2026, Align Technology reported revenue of $4.2 billion, about the same as a year earlier (+4.4%).
Its operating margin was 14.9%, up 1.5 percentage points from a year earlier: for every $100 of sales, about $15 was left as operating profit.
Net income was $492 million (11.8% of revenue), 30.0% higher than a year earlier.
Operating cash flow was $750 million and capital spending $147 million, leaving free cash flow of $603 million (14.5% of revenue).
At the end of the period it held $1.1 billion in cash and not reported in debt, a net cash position of $1.1 billion.
The diluted share count fell 1.9% in a year, typically the result of buybacks.
Five-year trend
- Revenue went from $2.5 billion in fiscal 2020 to $4.0 billion in fiscal 2025, about 10.3% a year.
- Revenue has grown for 3 fiscal years in a row.
- Operating margin narrowed from 15.7% to 13.5% over the same years.
- Free cash flow was positive in each of the last 6 fiscal years.
| Fiscal year | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $4.0B | $3.7B | $3.9B | $4.0B | $4.0B |
| Revenue growth | 59.9% | -5.5% | 3.4% | 3.5% | 0.9% |
| Operating margin | 24.7% | 17.2% | 16.7% | 15.2% | 13.5% |
| Net income | $772M | $362M | $445M | $421M | $410M |
| Free cash flow | $771M | $277M | $608M | $623M | $491M |
| Diluted EPS | $9.69 | $4.61 | $5.81 | $5.62 | $5.65 |
Fiscal years as reported in Align Technology’s 10-K filings. Free cash flow is operating cash flow minus capital spending.
Recent SEC filings
- 8-K filed November 6, 2026 — Material agreement; New debt obligation
- 10-Q filed November 4, 2026 — quarterly report
- 8-K filed October 28, 2026 — Executive or director change; Regulation FD disclosure
- 8-K filed October 28, 2026 — Earnings results
- 8-K filed August 31, 2026 — Executive or director change
- 10-Q filed August 5, 2026 — quarterly report
- 8-K filed July 29, 2026 — Regulation FD disclosure
- 8-K filed July 29, 2026 — Earnings results
Companies like Align Technology
Other S&P 500 companies in Health Care Supplies:
More from Health Care
Questions about Align Technology
Is Align Technology's revenue growing?
Yes. Revenue for the twelve months to September 30, 2026 was $4.2 billion, up 4.4% from a year earlier, according to its SEC filings.
Is Align Technology profitable?
Yes. It earned $492 million in net income over the twelve months to September 30, 2026, a net margin of 11.8%.
When did Align Technology last file financial results?
Its latest quarterly report (10-Q) was filed with the SEC on November 4, 2026.
Which companies are similar to Align Technology?
In the S&P 500, Align Technology is grouped in Health Care Supplies within the Health Care sector. Cooper Companies (The) (COO), West Pharmaceutical Services (WST) are in the same group.
Understand the numbers
Source: Align Technology’s filings with the U.S. Securities and Exchange Commission (EDGAR), retrieved November 11, 2026. Figures are as reported by the company and may be restated. This page is for information only and is not financial advice.